𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of the Epstein-Barr virus DNA polymerase in Escherichia coli for use as antigen for the diagnosis of nasopharyngeal carcinoma

✍ Scribed by Lung-Shen Lin; Lee-Hwa Ro; Mu-Shung Lo; Wan-Ling Huang; Jeng Ma; Tong-Hsuan Chang; Chih-Hung Shu; Kuan-Chih Chow; Wu-Tse Liu; Kuang Y. Chen; Huey-Lang Yang


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
722 KB
Volume
45
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Epstein‐Barr virus (EBV) encoded DNA polymerase (POL) was cloned and over‐expressed in Escherichia coli. Western blot analysis confirmed the presence of antibody to this POL protein in sera from nasopharyngeal carcinoma (NPC) patients. By Western blot analysis, moderate to high concentration of IgG POL‐specific antibodies were present in 43 of 48 NPC sera and only 4 of 48 healthy, seropositive controls. The POL‐specific IgG antibodies appear as early as stage I of NPC, suggesting that the recombinant POL protein can be a useful diagnostic marker for early diagnosis of the disease. It was also found that human sera containing high titer of cytomegalovirus (CMV) antibodies or herpes simplex virus type 1 (HSV‐1) antibodies did not cross‐react with the recombinant EBV POL, despite the homology shared by DNA polymerase proteins of these viruses. © 1995 Wiiey‐Liss, inc.


📜 SIMILAR VOLUMES


IgA directed against early antigen of Ep
✍ Gottfried Sigel; Monika Schillinger; Klaus Henninger; Georg Bauer 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract The aim of this study was to evaluate the significance and specificity of IgA directed against Epstein‐Barr virus (EBV)‐specific early antigens (EA) for the unequivocal diagnosis of nasopharyngeal carcinoma (NPC). Therefore, sera from patients with diseases other than NPC, selected on t

IgA antibodies against the Epstein-Barr
✍ Wajdi Ayadi; Héla Karray-Hakim; Lamia Feki; Abdelmajid Khabir; Tahia Boudawara; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract Serological tests for Epstein‐Barr virus (EBV) have been used for many years as diagnostic predictors of nasopharyngeal carcinoma. It has been shown previously that the conventional immunofluorescence assay has a limited diagnostic value, especially in young patients from North African

Antibody to Epstein-Barr virus-specific
✍ Jen-Yang Chen; Mei-Ying Liu; Chien-Jen Chen; Mow-Ming Hsu; Shih-Mien Tu; Hong-Hs 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

We have previously shown that high levels of antibody to Epstein-Barr virus (EBV)-specific DNase may be a useful marker for the early diagnosis of nasopharyngeal carcinoma (NPC). Sera from 3,368 males in an area with a high risk for the development of NPC were examined for the presence of antibody t

Epstein-Barr viral serology in nasophary
✍ V. Gurtsevitch; R. Ruiz; V. Stepina; I. Plachov; E. le Riverend; T. Glazkova; M. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 743 KB

Serological responses to Epstein-Barr virus (EBV)associated antigens were studied in nasopharyngeal carcinoma (NPC) patients in 2 countries non-endemic for the disease: the USSR (77 cases) and Cuba (55 cases). Two age-and sex-matched control groups were available, one consisting of patients with oth

Comparison of polymerase chain reaction
✍ Dr. Louise Pedneault; Ben Z. Katz 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 1007 KB

The sensitivity of the polymerase chain reaction (PCR) assay was compared to that of standard Southern blotting (SB) hybridization for detecting the presence of Epstein-Barr virus (EBV) genomes in biopsy samples from 43 patients with a variety of lymphoproliferative disorders. Two pairs of oligonucl